Christopher D Lao

  • 2918 Citations
  • 14 Scopus h-Index
20042021

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Merkel Cell Carcinoma Medicine & Life Sciences
Brain Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2021

Research Output 2004 2017

  • 2918 Citations
  • 14 Scopus h-Index
  • 23 Article
  • 6 Letter
  • 5 Review article
  • 2 Comment/debate

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)

Kalinsky, K., Lee, S., Rubin, K. M., Lawrence, D. P., Iafrarte, A. J., Borger, D. R., Margolin, K. A., Leitao, M. M., Tarhini, A. A., Koon, H. B., Pecora, A. L., Jaslowski, A. J., Cohen, G. I., Kuzel, T. M., Lao, C. D. & Kirkwood, J. M. 2017 In : Cancer.

Research output: Contribution to journalArticle

Melanoma
Extremities
Protein-Tyrosine Kinases
Disease-Free Survival
Confidence Intervals
Clinical Trials
1 Citations

Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases

Kim, M. M., Parmar, H., Cao, Y., Knox, S. J., Oronsky, B., Scicinski, J., Lawrence, T. S. & Lao, C. D. Mar 1 2016 In : Neuro-Oncology. 18, 3, p. 455-456 2 p.

Research output: Contribution to journalLetter

Melanoma
Radiotherapy
Neoplasm Metastasis
Brain
2 Citations

Implications of age and conditional survival estimates for patients with melanoma

Banerjee, M., Lao, C. D., Wancata, L. M., Muenz, D. G., Haymart, M. R. & Wong, S. L. 2016 In : Melanoma Research. 26, 1, p. 77-82 6 p.

Research output: Contribution to journalArticle

Melanoma
Confidence Intervals
Mortality
Decision Making
Epidemiology
4 Citations

Management of adverse events following treatment with anti-programmed death-1 agents

Weber, J. S., Postow, M., Lao, C. D. & Schadendorf, D. Oct 1 2016 In : Oncologist. 21, 10, p. 1230-1240 11 p.

Research output: Contribution to journalArticle

Melanoma
CTLA-4 Antigen
Endocrine System
Anniversaries and Special Events
Health Personnel